Elizabeth Kera Phd Llc Clinical Neuropsychologist Medicare: Not Enrolled in Medicare Practice Location: 909 Belmont Ave, North Haledon, NJ 07508 Phone: 201-615-0060 Fax: 201-941-4745 |
Lori Catania Phd. Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 909 Belmont Ave, North Haledon, NJ 07508 Phone: 201-427-4998 |
Innova Counseling And Wellness Center, Inc. Psychologist Medicare: Medicare Enrolled Practice Location: 681 High Mountain Rd, North Haledon, NJ 07508 Phone: 973-427-3255 |
Kaleidoscope Disabilities Inc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 810 Belmont Ave, 2nd Floor Suite 202, North Haledon, NJ 07508 Phone: 973-427-4251 Fax: 888-262-0085 |
Don Digiovine, Ph.d. Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 886 Belmont Ave, Suite # 3, North Haledon, NJ 07508 Phone: 973-423-3983 Fax: 201-891-7334 |
News Archive
A new report published by the Results for Development Institute in the Lancet "has offered governments and donors a glimpse into the future of HIV epidemics - and what it will cost to prevent and treat them. Researchers warn of hard choices ahead and a need for some countries to take more responsibility for their national programmes," IRIN/PlusNews reports. Study authors present their "cheapest" and "ideal" scenarios for HIV/AIDS funding in the future, according to IRIN/PlusNews.
President Obama is seeking to relieve concerns about possible Medicare changes and, at his New Hampshire town hall this week, highlighted issues affecting seniors.
Scientists at the University of California, San Diego (UCSD) School of Medicine have uncovered a novel pathway by which hormones elevated in inflammation, cancer and cell injury act on cells to stimulate their growth.
When scientists exposed pregnant mice to levels of bisphenol A equivalent to those considered safe in humans, three generations of female mouse offspring experienced significant reproductive problems, including declines in fertility, sexual maturity and pregnancy success, the scientists report in the journal Toxicology and Applied Pharmacology.
The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease. The patient was enrolled initially in a two week Phase 2a study in August 2007 where she received 100 mg per day of PRX-03140 in combination with her normal daily dose of Aricept(10 mg).
› Verified 6 days ago